Product Information
LEVETIRACETAM 500 MG TABLET is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.0739 per EA under NDC 27808026401. Its NADAC has been published 158 times since Aug 16, 2023.
FDA first approved this application on Dec 14, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Cranbury Pharmaceuticals, LLCNDC
27808026401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA091491FDA Approved
12/14/2010
TE Code
AB
On Market Since
5/1/2023
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 500 MG TABLET has been published 158 times since Aug 16, 2023, and over the history we have for it it has declined 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0739 per EA |
|---|---|
| All-time high | $0.0991 (Jan 10, 2024) |
| All-time low | $0.0608 (Nov 20, 2024) |
| 52-week high | $0.0799 |
| 52-week low | $0.0739 |
| Median price | $0.0784 |
| Average price | $0.0806 |
| Largest weekly change | -26.6% (Nov 20, 2024) |
| Weeks tracked | 158 |
| Tracking since | Aug 16, 2023 |
Generic Alternatives
The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 500 MG TABLET, manufactured by Cranbury Pharmaceuticals, LLC, is $0.0739 per EA (NDC 27808026401), effective Aug 19, 2026.
How has the price of LEVETIRACETAM 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 500 MG TABLET has declined 20.3%. It has been tracked across 158 weekly CMS publications since Aug 16, 2023.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 500 MG TABLET?
Since Aug 16, 2023, the NADAC for LEVETIRACETAM 500 MG TABLET has ranged from a low of $0.0608 (Nov 20, 2024) to a high of $0.0991 (Jan 10, 2024), with a median of $0.0784 per EA.
Are there cheaper alternatives to LEVETIRACETAM 500 MG TABLET?
Yes. 21 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 500 MG TABLET, is $0.0720 per EA — about 3% below LEVETIRACETAM 500 MG TABLET.
Who manufactures LEVETIRACETAM 500 MG TABLET?
LEVETIRACETAM 500 MG TABLET (NDC 27808026401) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.